The role of biomarkers in diagnosis of COVID-19 – A systematic review

Gorbalenya, 2020

Chan, 2003, Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS), Thorax, 58, 686, 10.1136/thorax.58.8.686

Booth, 2005, Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units, J. Infect. Dis., 191, 1472, 10.1086/429634

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 [cited 2020 Apr 28]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/.

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Pierce, 2012, Biomarkers: an important clinical assessment tool, Am. J. Nurs., 112, 52, 10.1097/01.NAJ.0000418926.83718.28

Gong, 2020

Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin. Infect. Dis.

Liu, 2020, Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19, J. Clin. Virol., 127, 10.1016/j.jcv.2020.104370

Ji, 2020

Yip, 2005, Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia, Clin. Chem., 51, 47, 10.1373/clinchem.2004.031229

Tan, 2020, C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early, J. Med. Virol., 10.1002/jmv.25871

Mahajan, 2019, Plcγ2/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome, J. Autoimmun., 100, 62, 10.1016/j.jaut.2019.02.005

Mahallawi, 2018, MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile, Cytokine, 104, 8, 10.1016/j.cyto.2018.01.025

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7

Coomes, 2020

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585

Tan, 2020, Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduction and Targeted Therapy, 5, 1

Han, 2020

Ferrari, 2020, Routine blood tests as a potential diagnostic tool for COVID-19, Clin. Chem. Lab. Med., 10.1515/cclm-2020-0398

Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 382, 1708, 10.1056/NEJMoa2002032

Xiong, 2020, Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes, Investig. Radiol., 55, 332, 10.1097/RLI.0000000000000674

Mo, 2020, Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China, Clin. Infect. Dis.

Zhang, 2018, Use of D-dimer in oral anticoagulation therapy, Int. J. Lab. Hematol., 40, 503, 10.1111/ijlh.12864

Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J. Thromb. Haemost., 18, 844, 10.1111/jth.14768

Zhang, 2020, D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19, J. Thromb. Haemost., 10.1111/jth.14859

Milbrandt, 2009, Prevalence and significance of coagulation abnormalities in community-acquired pneumonia, Mol. Med., 15, 438, 10.2119/molmed.2009.00091

Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis, Clin. Chim. Acta, 506, 145, 10.1016/j.cca.2020.03.022

Liu, 2020, Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study, Platelets, 0, 1

Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J. Thromb. Haemost. [Internet]. [cited 2020 Apr 30];n/a(n/a). Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14848.

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Shi, 2020, Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China, JAMA Cardiol., 10.1001/jamacardio.2020.0950

Henry, 2020, Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection, Int Urol Nephrol [Internet], 10.1007/s11255-020-02451-9

Xiang, 2020, Potential biochemical markers to identify severe cases among COVID-19 patients, medRxiv

Cheng, 2020, Kidney disease is associated with in-hospital death of patients with COVID-19, Kidney Int., 97, 829, 10.1016/j.kint.2020.03.005

Zhou, 2020

Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J. Thromb. Haemost., 18, 1094, 10.1111/jth.14817

Li, 2020, SAA is a biomarker to distinguish the severity and prognosis of coronavirus disease 2019 (COVID-19), J Infect [Internet]

Wang, 2020, C-reactive protein levels in the early stage of COVID-19, Med. Mal. Infect., 10.1016/j.medmal.2020.03.007

Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci. China Life Sci., 63, 364, 10.1007/s11427-020-1643-8

Liu, 2020, Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease, Chin. Med. J., 133, 1032, 10.1097/CM9.0000000000000775

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med., 46, 846, 10.1007/s00134-020-05991-x

Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir. Med., 8, 475, 10.1016/S2213-2600(20)30079-5

Young, 2020, Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore, JAMA, 323, 1488, 10.1001/jama.2020.3204

Chen, 2020, Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia, Zhonghua Jie He He Hu Xi Za Zhi, 43

Liu, 2020, The potential role of IL-6 in monitoring severe case of coronavirus disease 2019, medRxiv

Diao, 2020

Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern. Med., 10.1001/jamainternmed.2020.0994

Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Journal of Thrombosis and Haemostasis [Internet]. [cited 2020 Apr 25];n/a(n/a). Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14859.

Abuelgasim, 2020, COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities [published online ahead of print, 2020 May 8], Curr. Probl. Cardiol., 100621, 10.1016/j.cpcardiol.2020.100621

Khan, 2020, At the heart of COVID-19, J. Card. Surg., 10.1111/jocs.14596

Hashkhusha, 2020, ACE inhibitors and COVID-19: We don't know yet, J. Card. Surg.

Zaim, 2020, COVID-19 and Multi-Organ Response [published online ahead of print, 2020 Apr 28], Curr. Probl. Cardiol., 100618, 10.1016/j.cpcardiol.2020.100618

Savarimuthu, 2020, The role of ECMO in COVID-19: Can it provide rescue therapy in those who are critically ill?, J. Card. Surg., 10.1111/jocs.14635